
John Dobak, M.D. - ClicBio, Inc. - LinkedIn
2017年1月9日 · View John Dobak, M.D.’s profile on LinkedIn, a professional community of 1 billion members. John Dobak, M.D. has served as Founder and CEO of multiple life science companies. He…
- 500+ 连接数
- 位置: ClicBio, Inc.
10xBio | Innovations in Body Contouring
2023年8月16日 · John Dobak, M.D., is the Chairman of 10xBio. He has spent the last 25 years developing novel medical technologies. Most recently he served as the CEO of DermTech, the leader in genomics and precision medicine for dermatology. Dr. Dobak has founded numerous companies and led them through development to product launch and successful exits.
Leadership - DermTech
Meet the team that is defining the new era of precision dermatology with innovation, entrepreneurship, passion, and personal experience.
Pantherics, Inc. • John Dobak, MD
2022年9月27日 · John Dobak, MD, has served as Founder and CEO of several venture-backed life science companies in San Diego. Dr. Dobak is the President of the JAKK Group , a life sciences technology accelerator, which has created several companies, including Lithera, INNERCOOL Therapies, and CryoGen/CryoCor.
John Dobak Biography and Net Worth - InsiderTrades.com
Have questions about DermTech CEO John Dobak? View Dr. Dobak's net worth, biography, salary, age, and recent stock transactions at InsiderTrades.com.
John Dobak - library.ucsd.edu
2008年8月26日 · Dr. Dobak received his Bachelor’s Degree from UCLA and his M.D. from the UC, San Diego in 1992. He went on to serve as Chief Executive Officer with CryoCor, and Chief Executive Officer and founder of Intercool where he was a co-inventor of Intercool’s technology.
Dobak, John - The Wall Street Transcript
JOHN DOBAK, MD, is the Founder/CEO of INNERCOOL Therapies, Inc. INNERCOOL is an early stage company developing a novel therapeutic catheter to treat neurovascular and cardiovascular...
John Dobak - Innovators Under 35
After hitting a dead-end marketplace in dermatology and initially rebuffed by the technological challenges of cardiac surgery, Dobak eventually launched his first company, Cryogen, to make a new instrument for gynecologic cryotherapy.
DermTech, Inc. Announces John Dobak Expects to Step Away as …
2023年3月2日 · Dr. John Dobak will continue to serve as chief executive officer until the earlier of the date the Board appoints a successor and September 30, 2023. The Board has initiated a comprehensive search to identify Dr. Dobak's replacement.
John Dobak | MIT Technology Review
After hitting a dead-end marketplace in dermatology and initially rebuffed by the technological challenges of cardiac surgery, Dobak eventually launched his first company, Cryogen, to make a new...